Evidence map›Paper›PMID 25097830›Full record

ArticleJournal of clinical & translational endocrinology2014

The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes.

Susu M Zughaier, Jessica A Alvarez, John H Sloan, Robert J Konrad, Vin Tangpricha

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of clinical & translational endocrinology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03001687 (Impact of Vitamin D Enteral Supplementation on Hepcidin Serum Levels and Transfusion Requirements in Surgical and Critically Ill Patients), which is not on this map. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03001687 naunknown statusnot on this mapstarted 2017, after this paper: background citation

Impact of Vitamin D Enteral Supplementation on Hepcidin Serum Levels and Transfusion Requirements in Surgical and Critically Ill Patients

TypeinterventionalSponsorIuliu Hatieganu University of Medicine and PharmacyRan2017 to 2017Enrolled40ConditionsSystemic Inflammatory Response Syndrome, Sepsis, Surgical InjuriesArmsenteral supplementation with vitamin D, blood collection 3mL
3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it, 170 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. High-Dose Vitamin DJPEN. Journal of parenteral and enteral nutrition · 2018
    Trial
  6. High-dose vitamin DClinical nutrition (Edinburgh, Scotland) · 2017
    Trial
  7. Vitamin DEuropean journal of nutrition · 2017
    Trial
  8. Trial
  9. Trial
  10. Trial
  11. Changes in Mineral Micronutrient Status During and After Pulmonary Exacerbation in Adults With Cystic Fibrosis.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2015
    Trial
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Susu M ZughaierDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA ; Atlanta Veterans Affairs Medical Center, Atlanta, GA, USA.
Jessica A AlvarezDivision of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
John H SloanLilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
Robert J KonradLilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
Vin TangprichaDivision of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA ; Atlanta Veterans Affairs Medical Center, Atlanta, GA, USA.
Emory University · USEli Lilly (United States) · US

Funding

ENDOCRINOLOGY, METABOLISM, AND DIABETEST32DK007298 · NIDDK · EMORY UNIVERSITY · PI PACIFICI, ROBERTO · 1986 to 2014
$3.2M
NIDDK NIH HHS T32 DK007298
6 · The paper itself

Abstract

Chronic kidney disease affects 40% of adults aged 65 and older. Anemia of CKD is present in 30% of patients with CKD and is associated with increased cardiovascular risk, decreased quality of life, and increased mortality. Hepcidin-25 (hepcidin), the key iron regulating hormone, prevents iron egress from macrophages and thus prevents normal recycling of the iron needed to support erythropoiesis. Hepcidin levels are increased in adults and children with CKD. Vitamin D insufficiency is highly prevalent in CKD and is associated with erythropoietin hyporesponsiveness. Recently, hepcidin levels were found to be inversely correlated with vitamin D status in CKD. The aim of this study was to investigate the role of vitamin D in the regulation of hepcidin expression

Indexed as

Anemia of inflammationChronic kidney diseaseFerroportinHepcidinIL-1βIL-6MacrophageNRAMP1Vitamin D

Identifiers

PMID25097830
PMCPMC4119757
OpenAlexW1993877744

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.